Gary A. Lyons, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 5,000 shares at $110.54 ($553K) on 2022-10-04, disclosed to the SEC on 2022-10-05.
Open-market sale of $553k NBIX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2025-12-04 | $2.3M | — | Filing → |
| TVTX | SELL | 2024-10-04 | $1.2M | — | Filing → |
| NBIX | SELL | 2024-08-15 | $3.5M | — | Filing → |